We’re still feasting from our notes of the ACI Drug and Device Conference in New York last month. This post combines our thoughts with the ideas of one of the speakers at the conference. (We’re not sure if that person cares to be identified here, so we’re not naming him or her — but not
Wither The Privilege For In-House Counsel?
This guest post was written by David Booth Alden. Mr. Alden is a partner resident in the Cleveland office of Jones Day. This post is entirely his work. It of course represents only his views, and not the views of his clients or firm.
The privilege as applied to in-house attorneys